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Abstract
Data from surveys of large samples showed the lifetime prevalence rates of bipolar disorder around
1.5%. A main question is whether the low prevalence rates of bipolar disorders are not an artefact
of the over-diagnosis of depression and under-diagnosis of bipolar-II.
Analysis of the clinician's logical inferential diagnostic process, confirms that the patient does not
represent the sole source of useful information because many patients do not experience
hypomania as distress but rather as recovery from depression or as a period during which they felt
truly well.
Epidemiological data are derived from interviews carried out by lay staff which only reflect the
patient's point of view.
The clinical monitoring study carried out alongside the ESEMED project found for the diagnosis of
mood disorders, a Kappa agreement (versus clinical interview) which ranged from 0.23 in Spain to
0.49 in France.
If we consider exactly what a Kappa of 0.4 implies for a disorder with an "identified" prevalence
rate of 2%, we discover that the prevalence rate may have been under-diagnosed approximately
1.5-fold, so 67% of cases may not have been identified and 50% of the identified cases may be false
positives.
It is legitimate to surmise that the prevalence reported by recent (extremely costly)
epidemiological surveys may be doubtful.
Which direction should epidemiology take in dealing with the serious matter of bipolar disorders?
Recently, some community surveys were carried out in the USA using the Mood Disorder
Questionnaire. In the ensuing debate, one side claimed that the instrument was scarcely accurate
when used in the general population, gave rise to numerous false positives and that the high
prevalence reported was therefore a mere artefact. The other side defended the results reported
by the research studies, on the basis that "positive" cases were homogeneous with regard to the
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high level of subjective distress, low social functioning and employment and with the high recourse
to health care structures.
It is quite probable that the problem lies at the root of the matter, in the definition of the gold
standard.
In the present state of our knowledge on course and response to treatment, the current diagnostic
thresholds applied for mixed states and hypomanic episodes seem to be unsatisfactory.
It is inconceivable that the diagnostic gold standard should be determined only on the basis of a
structured interview of patients alone. But unless there is clinical consensus on the diagnostic
threshold for hypomania and mixed states, there can be no consensus on the findings of
epidemiological research.
To our readers
This commentary is the first of a series designed to intro-
duce the new online journal Clinical Practice and Epidemi-
ology in Mental Health.
Based on the characteristics that were described in the first
editorial and by means of a series of introductory com-
mentaries, the journal will seek to stimulate discussion of
the main psychiatric topics facing clinical and epidemio-
logical research across the scientific community. An edito-
rial board of international renown will both chair these
debates and actively contribute to this series. .
It is no mere chance that the first commentary deals with
bipolar disorders, arguably a leading issue in current psy-
chiatric research. In spite of the importance of the topic, a
number of researchers maintain that it is not adequately
taken into account in the medical field, probably due to
the marked inconsistency in the available epidemiological
data.
Bipolar disorders today
Are we right then in defining the field of bipolar disorders
as a poorly recognized medical problem? Apparently not.
The World Health Organization has defined bipolar disor-
ders as one of the leading causes of disability throughout
the world [1].
In the fields of clinical practice and prevention, it is often
underlined that bipolar disorders represent a devastating
risk factor for both suicide attempts and suicide itself [2].
It is a well-known fact that subjects affected by this disor-
der are grossly penalized in the area of employment [3]
The high costs of bipolar disorders
The financial implications of bipolar disorders are only
just beginning to be taken into account.
The first studies carried out on the costs of bipolar disor-
ders indicate expenditures ranging between 24 and 30 bil-
lion US$ in the United States over a one year period [4].
Data obtained from an American insurance company
reveal how patients affected by bipolar disorders, i.e. 3%
of subjects seeking medical assistance, account for 12% of
total expenditure [5]. The author of the paper concludes
that this is "the most expensive behavioral health care
diagnosis". However, the same author reports that this
expenditure is largely concerned with the cost of inpatient
care of subjects diagnosed years after onset of the disorder,
suggesting that the financial burden could therefore be
lessened.
On the other hand, very few data are available on indirect
costs, although these, too, are estimated to be extremely
high. A study performed in the United States in 1991
(published in 1995) reported that indirect costs repre-
sented 83% of the total expenditure [6].
Is the prevalence of bipolar disorder really low?
However, if we analyze data from surveys of large samples
at both national and trans-national level, the prevalence
rates of bipolar disorder are dramatically low. The ECA
study reports a prevalence rate for bipolar disorders of
1.5% in the general population, of which only 0.3% are
bipolar II. The National Comorbidity study indicates a
lifetime prevalence for mania and hypomania of 1.6% [7].
More recent data from the Netherlands (NEMESIS Study)
also suggested a low prevalence rate for bipolar disorder
of 1.9% [8]. The as yet unpublished findings reported by
the recent multi-center European study ESEMED reveal
even lower frequencies, under 1%. Although several
reviews of studies performed on smaller samples do not
exactly confirm these findings, it is the larger studies
which determine the opinions of the managers of health
and research programs. Accordingly, bipolar disorders
would not appear to have the same degree of impact on
public health as major depressive disorders. Indeed, the
leading international studies on major depressive disor-
ders show a lifetime prevalence rate ranging from 3 to
17% in western societies, with an upward trend being evi-
denced in recent research projects [9]. A main question is
whether the low prevalence rates of bipolar disorders areClinical Practice and Epidemiology in Mental Health 2005, 1:4 http://www.cpementalhealth.com/content/1/1/4
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not an artefact of the over-diagnosis of depression and
under-diagnosis of bipolar-II.
The definition of bipolar spectrum disorders
The current definitions of mixed state, hypomania and
bipolar disorder II are not, however, universally accepted.
In clinical practice very few psychiatrists apply a diagnos-
tic threshold for mixed states as high as that indicated by
DSM-IV (full criteria for a depressive and manic episode).
The impressions held by many clinicians are supported by
the findings of a twenty-year longitudinal community
study carried out in Zurich [2], which found that depres-
sives with a subthreshold hypomanic syndrome were sim-
ilar to bipolar II disorders in terms of positive family
history for mania, course, comorbidity and treatment
rates. Moreover, sub-threshold manic symptoms in ado-
lescence appear to be highly predictive of the subsequent
onset of manic episode [10].
Decisive sources of information and under-
diagnosis of bipolar disorders
A further explanation for the apparently low prevalence
reported by epidemiological studies may be that the
methodological instruments used have led to an under-
diagnosis of cases of bipolar disorder.
Analysis of the clinician's logical inferential diagnostic
process, particularly when diagnosing bipolar disorder,
confirms that the patient does not represent the sole
source of useful information. At times, the patient's
spouse, a relative or a close friend will refer fundamental
information, often because many patients do not experi-
ence hypomania as distress but rather as recovery from
depression or as a period during which they felt truly well.
One of the clinician's tasks is to cross check the statements
of the patient and significant others and to act as a medi-
ator between them.
Accordingly, the clinician will attempt to convey relatives'
comments to the patient in order to create an awareness
that others may view his behavior as pathological. More-
over, in the course of the logical procedure leading to
diagnosis, it is not only what the patient says that should
be taken into account, but also the way in which he or she
says it and the coherence of his or her ideas.
It is not the patient's views that determine the diagnosis,
but rather the clinician's judgment. We are all well aware
of how far the views of a patient in a hypomanic state may
differ from the clinical judgment, particularly in the case
of a patient who has never received any form of treatment
and who therefore has not yet accepted the medical model
of the illness.
In the IOWA STUDY (a prospective investigation of the
hereditary nature of schizophrenia and bipolar disorders)
the prevalence of mania among relatives of patients
affected by bipolar disorders, calculated solely on the
basis of diagnostic interviews, was 1.9%; however, when
additional sources of information such as clinical records
and cross-interviewing of relatives were considered, the
rate increased to 5.3% [11].
Interviews
Epidemiological data are derived from interviews carried
out by lay staff, which only reflect the patient's point of
view. These instruments may at times be so highly struc-
tured that they do not allow any interaction between the
clinician's judgment and the diagnostic algorithm. The
accuracy of diagnosis of the lay interviews is measured by
comparison with the so-called "clinical" interviews, which
are again based on the patient as the source of informa-
tion. Less structured and more clinically-oriented tools
such as SCAN [12] are rarely used for the validation of epi-
demiological interviews.
Basically then, the instruments used to validate epidemio-
logical interviews are semi-structured conversations car-
ried out by clinicians, although the diagnostic algorithm
continues to be based to a large degree on patient's
response. The gold standard applied for validating the
diagnosis of bipolar disorder is much poorer than the free
clinical judgment would be.
In view of all these limitations the degree of reliability
remains low.
The clinical monitoring study carried out alongside the
ESEMED project found for the diagnosis of mood disor-
ders, a Kappa agreement (versus a clinical interview)
which ranged from 0.23 in Spain to 0.49 in France [13].
The researchers considered this to be satisfactory!
If we consider exactly what a Kappa of 0.4 implies for a
disorder with an "identified" prevalence rate of 2%, we
discover that the prevalence rate may have been under-
diagnosed approximately 1.5-fold, so 67% of cases may
not have been identified and fifty percent of the identified
cases may be false positives (table 1).
It is legitimate to surmise that the prevalence reported by
recent (extremely costly) epidemiological surveys may be
doubtful.
The way ahead
Which direction should epidemiology take in dealing
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Recently, some community surveys carried out in the USA
using the Mood Disorder Questionnaire as a screening
tool suggested a prevalence for bipolar disorders of
slightly less than 4% [14]. In the ensuing debate, one side
claimed that the instrument was scarcely accurate when
used in the general population, gave rise to numerous
false positives and that the high prevalence reported was
therefore a mere artefact [15]. The other side defended the
results reported by the research studies, on the basis that
"positive" cases were homogeneous with regard to the
high level of subjective distress, low social functioning
and employment and with the high recourse to health
care structures [16]. It is quite probable that the problem
lies at the root of the matter, in the definition of the gold
standard.
In the present state of our knowledge on course and
response to treatment, the current diagnostic thresholds
applied for mixed states and hypomanic episodes seem to
be unsatisfactory.
If we accept the arguments put forward here, it is incon-
ceivable that the diagnostic gold standard should be deter-
mined only on the basis of a structured interview of
patients alone. But unless there is clinical consensus on
the diagnostic threshold for hypomania and mixed states,
there can be no consensus on the findings of epidemio-
logical research.
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Table 1: Simulation of the agreement between two instruments 
where Kappa = 0.4 for a condition with a prevalence of 3% 
(SCID) identified as 2%
SCID + SCID - TOTAL
Bipolar cases Not bipolar cases
CIDI + 1 1 2
CIDI - 2 96 98
TOTAL 3 97 100